SEC Form D · filed December 1, 2023
Cartesian Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Timothy S. Barabe · Gaithersburg, MDDirectorMurat S. Kalayoglu · Gaithersburg, MDDirectorMichael S. Singer · Gaithersburg, MDDirectorCarsten Brunn · Gaithersburg, MDExecCarrie S. Cox · Gaithersburg, MDDirectorNishan S. De Silva · Gaithersburg, MDDirectorAymeric S. Sallin · Gaithersburg, MDDirectorPatrick S. Zenner · Gaithersburg, MDDirectorBlaine Davis · Gaithersburg, MDExecNishan S. De Silva · Gaithersburg, MDDirectorMichael S. Singer · Gaithersburg, MDDirectorMurat S. Kalayoglu · Gaithersburg, MDDirectorTimothy S. Barabe · Gaithersburg, MDDirectorAymeric S. Sallin · Gaithersburg, MDDirectorCarrie S. Cox · Gaithersburg, MDDirectorBlaine Davis · Gaithersburg, MDExecPatrick S. Zenner · Gaithersburg, MDDirectorCarsten Brunn · Gaithersburg, MDExecLance M. Zarb · Sydney, New South Wales, Channel IslandsDirectorFrewen M. Lam · Sydney, New South Wales, Channel IslandsExecJames M. Hoegh · Leeds, ALDirectorPamela M. Miller · Leeds, ALDirectorMichael M. Lukin · Sydney, New South Wales, Channel IslandsDirectorR. N. Malik · Manhattan Beach, CADirectorRonald E. Cano Ii · Manhattan Beach, CADirectorHasan N. Askari · Manhattan Beach, CAExecMark Whitehouse · Phoenix, AZDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗